Sökning: "reference group t"
Visar resultat 1 - 5 av 40 avhandlingar innehållade orden reference group t.
1. The leukocyte complexity and mutational landscape of periampullary adenocarcinoma. Morphology matters
Sammanfattning : Background: Periampullary adenocarcinomas are a heterogenous group of tumours with poor prognosis that hasnot improved considerably the last decades. Tumour morphology, i.e. intestinal type (I-type) or pancreatobiliarytype (PB-type), has been demonstrated to be a more relevant prognostic factor than anatomical origin. LÄS MER
2. Characterization of the Intestinal Microbiota by DNA-Based Methods
Sammanfattning : The intestinal flora and the bacteria found in the extraintestinal sites were studied in liver injury rats, with or without Lactobacillus plantarum 299v pre-treatment. The dominating intestinal flora and translocating bacteria were typed by RAPD and identified by 16S rDNA sequencing. LÄS MER
3. Aspects of Plasminiogen Activator Inhibitor 1 in Metabolic Syndrome
Sammanfattning : Plasminogen activator inhibitor 1 (PAI-1) is the main inhibitor of the fibrinolytic system and binds irreversibly to tissue-type plasminogen activator (t-PA), and thereby inhibits the protective action of t-PA against thrombus formation. Elevated levels of plasma PAI-1 is observed in subjects with type 2 diabetes (T2D) and the metabolic syndrome (MetS), which is a combination of metabolic features including obesity. LÄS MER
4. Clinical and immunopathological studies in Hodgkin's disease with special reference to prognosis
Sammanfattning : Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) have certain features in common, but also distinct clinical and pathological differences. Thus, HD has many features of both an infectious (fever, leukocytosis, eosinophilia, night sweats, lymphadenopathy, splenomegaly) and a malignant process with few tumour cells, T-cell accumulation and sclerosis. LÄS MER
5. Bleeding complications after acute coronary syndrome with special reference to intracranial hemorrhage
Sammanfattning : Background: Bleeding complications following acute coronary syndrome (ACS) have attracted considerable attention in recent years. The gradual implementation of new evidence-based treatments in patients with ACS, with a focus on anti-ischemic therapy, has reduced the risk of ischemic events (new myocardial infarction or ischemic stroke) but at the expense of increased bleeding risk. LÄS MER